日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterization of novel small molecule inhibitors of estrogen receptor-activation function 2 (ER-AF2)

雌激素受体活化功能 2 (ER-AF2) 新型小分子抑制剂的表征

Jane Foo, Francesco Gentile, Shabnam Massah, Helene Morin, Kriti Singh, Joseph Lee, Jason Smith, Fuqiang Ban, Eric LeBlanc, Robert Young, Natalie Strynadka, Nada Lallous #, Artem Cherkasov #

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants

一类新型广谱活性位点定向 3C 样蛋白酶抑制剂,具有纳摩尔级抗病毒活性,可对抗高度免疫逃避型 SARS-CoV-2 Omicron 亚变体

Jimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, Anh-Tien Ton, Jaeyong Lee, Ivan Villanueva, Connor A H Thompson, Svenja Dudek, Siobhan Ennis, Jason R Smith, Tirosh Shapira, Joshua De Guzman, Shutong Gang, Fuqiang Ban, Marija Vuckovic, Michael Bielecki, Suzana Kovacic, Calem Kenward, Christop

Development of VPC-70619, a Small-Molecule N-Myc Inhibitor as a Potential Therapy for Neuroendocrine Prostate Cancer

开发小分子 N-Myc 抑制剂 VPC-70619 作为神经内分泌前列腺癌的潜在疗法

Anh-Tien Ton, Jane Foo, Kriti Singh, Joseph Lee, Anastasia Kalyta, Helene Morin, Carl Perez, Fuqiang Ban, Eric Leblanc, Nada Lallous, Artem Cherkasov

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics

发现用于抗癌治疗的新型催化拓扑异构酶 II 抑制剂

Victor M Matias-Barrios, Mariia Radaeva, Yi Song, Zaccary Alperstein, Ahn R Lee, Veronika Schmitt, Joseph Lee, Fuqiang Ban, Ning Xie, Jianfei Qi, Nada Lallous, Martin E Gleave, Artem Cherkasov, Xuesen Dong

Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer

开发针对雄激素受体 N 端结构域的雄激素受体抑制剂,用于治疗去势抵抗性前列腺癌

Fuqiang Ban, Eric Leblanc, Ayse Derya Cavga, Chia-Chi Flora Huang, Mark R Flory, Fan Zhang, Matthew E K Chang, Hélène Morin, Nada Lallous, Kriti Singh, Martin E Gleave, Hisham Mohammed, Paul S Rennie, Nathan A Lack, Artem Cherkasov

Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site

具有生理 C 端自加工位点的野生型 SARS-CoV-2 主蛋白酶酰基酶中间体的晶体结构

Jaeyong Lee, Liam J Worrall, Marija Vuckovic, Federico I Rosell, Francesco Gentile, Anh-Tien Ton, Nathanael A Caveney, Fuqiang Ban, Artem Cherkasov, Mark Paetzel, Natalie C J Strynadka

Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models

伊维菌素抑制 HSP27 并增强肿瘤模型中致癌基因靶向的功效

Lucia Nappi, Adeleke H Aguda, Nader Al Nakouzi, Barbara Lelj-Garolla, Eliana Beraldi, Nada Lallous, Marisa Thi, Susan Moore, Ladan Fazli, Dulguun Battsogt, Sophie Stief, Fuqiang Ban, Nham T Nguyen, Neetu Saxena, Evgenia Dueva, Fan Zhang, Takeshi Yamazaki, Amina Zoubeidi, Artem Cherkasov, Gary D Bray

Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer

N-Myc 和 AURKA 双重抑制剂可作为神经内分泌前列腺癌的潜在疗法

Anh-Tien Ton, Kriti Singh, Hélène Morin, Fuqiang Ban, Eric Leblanc, Joseph Lee, Nada Lallous, Artem Cherkasov

Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer

GMC1(一种用于治疗去势抵抗性前列腺癌的新型 FKBP52 辅分子伴侣抑制剂)的药代动力学研究的生物分析检测开发和验证

Oscar Ekpenyong, Candace Cooper, Jing Ma, Naihsuan C Guy, Ashley N Payan, Fuqiang Ban, Artem Cherkasov, Marc B Cox, Dong Liang, Huan Xie

Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells

黑色素瘤和前列腺癌细胞中泛素连接酶 Siah1/2 的小分子抑制剂的鉴定和表征

Yongmei Feng, E Hampton Sessions, Fan Zhang, Fuqiang Ban, Veronica Placencio-Hickok, Chen-Ting Ma, Fu-Yue Zeng, Ian Pass, David B Terry, Gregory Cadwell, Laurie A Bankston, Robert C Liddington, Thomas D Y Chung, Anthony B Pinkerton, Eduard Sergienko, Martin Gleave, Neil A Bhowmick, Michael R Jackson